2. Academic Validation
  3. Phase II study of anhydro-ara-5-fluorocytidine in adenocarcinoma of gastrointestinal tract, epidermoid carcinoma of lung, head and neck, breast carcinoma and small cell anaplastic carcinoma of lung. A study report of the E.O.R.T.C. early clinical trial cooperative group

Phase II study of anhydro-ara-5-fluorocytidine in adenocarcinoma of gastrointestinal tract, epidermoid carcinoma of lung, head and neck, breast carcinoma and small cell anaplastic carcinoma of lung. A study report of the E.O.R.T.C. early clinical trial cooperative group

  • Eur J Cancer (1965). 1978 Feb;14(2):195-201. doi: 10.1016/0014-2964(78)90178-0.
P Alberto,  M Rozencweig,  D Gangji,  A Brugarolas,  F Cavalli,  P Siegenthaler,  H H Hansen,  R Sylvester
PMID: 75105 DOI: 10.1016/0014-2964(78)90178-0
Figures
Products